DUBLIN--(BUSINESS WIRE)--The "Global Monoclonal Antibodies in Veterinary Health Market Size, Trends & Growth Opportunity, By Application, By Animal Type, By End-User By Region and Forecast to 2027." report has been added to ResearchAndMarkets.com's offering.
Global Monoclonal Antibodies in Veterinary Health Market Size, Trends & Growth Opportunity, By Application (Dermatology, Pain, Others), By Animal Type (Dogs, Others), By End-User (Veterinary Hospitals, Others.) By Region and Forecast till 2027.
Global Monoclonal Antibodies in Veterinary Health Market
The global Monoclonal Antibodies in Veterinary Health market was valued at USD 0.77 billion in 2021 which expected to reach USD 2.47 billion by 2027 at a CAGR 16.27%from 2021-2027.
Monoclonal antibodies are medications that act like your own antibodies and can assist to keep your symptoms from worsening and may prevent hospitalization due to worsening COVID-19 symptoms. This is NOT a vaccine replacement; rather, it is used to treat your present COVID-19 infection. The rising prevalence of atopic dermatitis, as well as the rising pet adoption rate, are driving market expansion. Furthermore, increased R&D spending by market participants for the development of cancer treatments is expected to fuel market expansion over the forecast period.
Market Drivers
The increasing frequency of canine atopic dermatitis is also predicted to function as a driving factor in market expansion. Canine atopic dermatitis is a genetic clinical condition that affects domestic dogs. Furthermore, atopic dermatitis is the most common cause of itchy allergic skin illness in dogs.
According to Frontiers Media S.A. research published in October 2020, the disease is predicted to impact 10-15% of the canine population. According to the publication, this figure is anticipated to rise over time. Market participants like Zoetis have goods like Cytopoint, the first monoclonal antibody treatment for allergic and atopic dermatitis.
Market Segmentation
The Global Monoclonal Antibodies in Veterinary Health Market is segmented into Application, Animal Type, Distribution Channel and Growing System. By Application such as Dermatology, Pain, Others. By Animal Type such as Dogs, Others. By End-User such as Veterinary Hospitals, Others.
Regional Analysis
Global Monoclonal Antibodies in Veterinary Health Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the Monoclonal Antibodies in Veterinary Health market in North America is expected to grow at the fastest CAGR. This is due to the different programmes launched by the government and commercial sector, as well as the growing popularity of pet insurance.
Furthermore, the presence of important organizations in the United States is expected to support market growth. According to the North American Pet Health Insurance Association, Inc., the pet insurance sector has grown at a significant pace of 23.4% in recent years. Furthermore, by the end of 2020, around 3.45 million pets were covered across North America.
The Asia Pacific market is expected to develop at the fastest CAGR during the forecast period, owing to the increasing emergence of local companies and the growing number of veterinary hospitals and clinics. Furthermore, the growing adoption of pets, as well as increased knowledge of their ailments and the availability of treatment choices, are projected to drive market expansion.
Market Taxonomy
By Application
- Dermatology
- Pain
- Others
By Animal Type
- Dogs
- Others
By End-User
- Veterinary Hospitals
- Others
By Region
- North America
- Latin America
- Europe
- China
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Monoclonal Antibodies in Veterinary Health Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Global Monoclonal Antibodies in Veterinary Health Market Outlook
5 Global Monoclonal Antibodies in Veterinary Health Market, By Application
6 Global Monoclonal Antibodies in Veterinary Health Market, By Animal Type
7 Global Monoclonal Antibodies in Veterinary Health Market, By End-User
8 Global Monoclonal Antibodies in Veterinary Health Market, By Region
9 North America Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
10 Europe Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
11 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
12 Latin America Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
13 Middle East Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
14 Competitive Analysis
15 Company Profiles
Companies Mentioned
- Zoetis
- Merck & Co Inc.
- Elanco
- Boehringer Ingelheim GmbH
- Indian Immunologicals Ltd
- Virbac
For more information about this report visit https://www.researchandmarkets.com/r/ly7fmq
